A cell‐based functional study further confirmed that YWHAZ overexpression can drive bladder cancer toward resistance to chemo‐/radio‐therapy which can be proven by IHC staining on recurrent UCUBs after chemotherapy (Figures 4 and 5). This evidence concerns the gene YWHAZ and urinary bladder cancer.